Open

Pro00107408

To determine if your treatment for your metastatic renal cancer has affected your daily life or quality of life.

Age & Gender

19 years ~ 99 years
Male, Female

Visit Availability

Standard business hours (M-F, 8-5)

Location

United States (Nationwide)

What will be asked of you

You will have a blood draw at the first visit and will complete questionnaires at every visit.

Incentives

Participants are eligible to receive $75 stipend and travel reimbursement (e.g. reimbursement for gas mileage and hotel costs) for their initial in-person visit.

In-person visits:
up to 2

Phone or online visits:
up to 10

Total length of participation:
3 years

Looking for Specific Volunteers

Able to participate:

You are at least 19 years old
You are diagnosed with metastatic renal cell cancer receiving therapy.
You sign the informed consent document.
You comply with completion of questionnaires.

Not eligible if:

You are being treated form metastatic solid tumors no considered metastatic renal cell carcinoma.
You are not intending to receive follow-up care at UNC

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

NC Cancer Hospital (Basnight)
UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Tracy Rose
LCCC - Clinical Trials

Study Type

Clinical or Medical
Observational

Study Topics

Cancer (Kidney)

IRB Number

23-2403

ClinicalTrials.gov

NCT04919122

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.